Researchers in Australia have unveiled a groundbreaking "Atlas of the Heart," a detailed map of chemical signals that control heart function. This online resource, Cardiopedia-Ligand, is a game-changer for heart disease research, offering a comprehensive understanding of how the heart responds to various biological signaling molecules. The study, published in Cell Stem Cell, utilizes human cardiac organoids, miniature heart tissues grown in labs, to measure tissue contraction and gene activity. This approach generates a vast dataset linking signaling with heart function and gene expression.
The atlas, created by Australia's QIMR Berghofer Medical Research Institute, catalogs responses to 87 biological signaling molecules. It's a valuable tool for researchers, clinicians, and the industry, providing a foundation for advancements in heart disease diagnosis, treatment, and prevention. Professor James Hudson, head of the Cardiac Bioengineering Laboratory, emphasizes the atlas's potential to revolutionize heart disease understanding.
The atlas is publicly accessible online, marking the first phase of a larger initiative. The next step involves screening 2,000 drug compounds to refine the map of heart biology and responses to potential therapies. The ultimate goal is to personalize medicine, matching patients' genetics and biomarkers to effective drugs, potentially transforming heart failure treatment.
This development is a significant leap forward in heart disease research, offering a detailed understanding of heart function and a platform for developing targeted therapies. The atlas's availability worldwide is a testament to the collaborative spirit of scientific research, paving the way for improved heart health outcomes globally.
